Evidence map›Paper›PMID 33426933›Full record

ArticleAnnals of medicine2021

Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice.

Toby Richards, Christian Breymann, Matthew J Brookes, Stefan Lindgren, Iain C Macdougall, Lawrence P McMahon, Malcolm G Munro, Elizabeta Nemeth, Giuseppe M C Rosano, Ingolf Schiefke and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Annals of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06521879 (Improved Gastrointestinal Tolerance and Iron Status Via Probiotic Use in Iron Deficiency Anemia Patients Initiating Oral Iron Replacement), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06521879 nacompletednot on this mapstarted 2022, after this paper: background citation

Improved Gastrointestinal Tolerance and Iron Status Via Probiotic Use in Iron Deficiency Anemia Patients Initiating Oral Iron Replacement

TypeinterventionalSponsorAntalya Training and Research HospitalRan2022 to 2023Enrolled295ConditionsIron Deficiency Anemia Treatment, Iron Deficiency AnemiaArmsLactobacillus plantarum 299v probiotic support
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Patient Blood Management in Pregnancy.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 8 countries.

Toby RichardsFaculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.ORCID 0000-0001-9872-4653
Christian BreymannObstetric Research-Feto Maternal Haematology Unit, University Hospital Zurich, Zurich, Switzerland.
Matthew J BrookesGastroenterology Unit, Royal Wolverhampton NHS Trust, Wolverhampton, UK.
Stefan LindgrenDepartment of Gastroenterology and Hepatology, Lund University, Skåne University Hospital, Malmö, Sweden.
Iain C MacdougallDepartment of Renal Medicine, King's College Hospital, London, UK.
Lawrence P McMahonDepartments of Renal Medicine and Obstetric Medicine, Eastern Health Clinical School, Monash University, Melbourne, Australia.
Malcolm G MunroDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Elizabeta NemethCenter for Iron Disorders, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Giuseppe M C RosanoDepartment of Medical Sciences, IRCCS San Raffaele, Roma, Italy.
Ingolf SchiefkeDepartment of Gastroenterology, Hepatology, Diabetology and Endocrinology, Klinikum St. Georg, Leipzig, Germany.
Günter WeissDepartment of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.
Eastern Health · AUInnsbruck Medical University · ATKaiser Permanente · USKing's College Hospital · GBKlinikum St. Georg · DELund University · SEThe University of Western Australia · AUUniversity of California, Los Angeles · USUniversity of Wolverhampton · GBUniversity of Zurich · CHVita-Salute San Raffaele University · IT

Funding

Ferroportin Structure and functionR01DK107309 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JORMAKKA, MIKA, MACKENZIE, BRYAN · 2015 to 2019
$3.0M
Iron physiology and pathology in pregnancyR01HD096863 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEMETH, ELIZABETA · 2019 to 2023
$2.1M
Department of Health 10/104/06NICHD NIH HHS R01 HD096863NIDDK NIH HHS R01 DK107309
6 · The paper itself

Abstract

Iron deficiency is a common cause of morbidity and can arise as a consequence or complication from many diseases. The use of intravenous iron has increased significantly in the last decade, but concerns remain about indications and administration. Modern intravenous iron preparations can facilitate rapid iron repletion in one or two doses, both for absolute iron deficiency and, in the presence of inflammation, functional iron deficiency, where oral iron therapy is ineffective or has not worked. A multidisciplinary team of experts experienced in iron deficiency undertook a consensus review to support healthcare professionals with practical advice on managing iron deficiency in gastrointestinal, renal and cardiac disease, as well as; pregnancy, heavy menstrual bleeding, and surgery. We explain how intravenous iron may work where oral iron has not. We provide context on how and when intravenous iron should be administered, and informed opinion on potential benefits balanced with potential side-effects. We propose how intravenous iron side-effects can be anticipated in terms of what they may be and when they may occur. The aim of this consensus is to provide a practical basis for educating and preparing staff and patients on when and how iron infusions can be administered safely and efficiently. Key messages Iron deficiency treatment selection is driven by several factors, including the presence of inflammation, the time available for iron replenishment, and the anticipated risk of side-effects or intolerance. Intravenous iron preparations are indicated for the treatment of iron deficiency when oral preparations are ineffective or cannot be used, and therefore have applicability in a wide range of clinical contexts, including chronic inflammatory conditions, perioperative settings, and disorders associated with chronic blood loss. Adverse events occurring with intravenous iron can be anticipated according to when they typically occur, which provides a basis for educating and preparing staff and patients on how iron infusions can be administered safely and efficiently.

Indexed as

Administration, IntravenousIron DeficienciesAdministration, OralClinical Decision-MakingConsensusFemaleHumansIron CompoundsMalePractice Guidelines as TopicPregnancyIron CompoundsAnaemiacardiovascular diseaseschronicerythrocyte transfusioninflammatory bowel diseasesinfusionsintravenousironiron-deficiencymenorrhagiapregnancy complicationsrenal insufficiency

Identifiers

PMID33426933
PMCPMC7877947
OpenAlexW3120042682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.